Evotec-RSIL celebrates first full year of operations with new contracts

Evotec-RSIL, the joint venture set up in 2007 between Evotec and the Indian cro Research Support International Limited (RSIL) is celebrating its first year of operation with two new contracts with global pharmaceutical companies in Europea and the US for the synthesis and supply of compound libraries.

In its inaugural year the company has signed collaborations with a total of five companies. In the latest deals Evotec-RSIL will use its skills and expertise in parallel synthesis, purification and analysis to synthesise and purify hit discovery libraries of hundreds to thousands of high quality compounds in the format specified by the customer.

Evotec-RSIL was set up to offer high quality, low cost services for the parallel synthesis of compound libraries to the pharmaceutical and biotechnology industry. State-of-the-art equipment and specific expertise was provided by Evotec to RSIL's purpose built, high spec laboratories in Thane, near Mumbai, India. The relocation of key senior scientists to the joint venture's new facility in India was also instrumental in ensuring the smooth integration of the techniques and procedures developed at the Evotec laboratories.

"We are pleased and proud that we are now supporting two of the world's leading pharmaceutical companies," said Lester Marrison, cso of Evotec-RSIL. "These two contracts, together with those signed over the past 12 months, are validation of our ability to provide high quality compound libraries in a cost efficient manner. We are looking forward to a further good year in 2009."